These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19517837)

  • 1. [Role of vascular endothelial growth factor in the pathogenesis of diabetic retinopathy].
    Sarygina OI; Neroev VV; Levkina OA
    Vestn Oftalmol; 2009; 125(2):58-60. PubMed ID: 19517837
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus].
    Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB
    Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of vascular endothelial growth factor (VEGF)].
    Urban B; Peczyńska J
    Klin Oczna; 2003; 105(5):319-21. PubMed ID: 14746189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of transforming growth factor-beta in the pathogenesis of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2006; 63(5):296-8. PubMed ID: 17036509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular endothelial growth factor (VEGF)].
    Iesato Y; Murata T
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():250-4. PubMed ID: 21667483
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy.
    Antonetti DA; Klein R; Gardner TW
    N Engl J Med; 2012 Mar; 366(13):1227-39. PubMed ID: 22455417
    [No Abstract]   [Full Text] [Related]  

  • 8. [Angiogenesis and diabetic retinopathy: specific connections to neuroretinal tissue].
    Paques M; Massin P; Bonnel S; Sahel JA
    Journ Annu Diabetol Hotel Dieu; 2005; ():33-7. PubMed ID: 16161303
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of timing of secretion of vascular endothelial growth factors is responsible for progression of diabetic retinopathy.
    Mondal LK; Baidya KP; Bhaduri G; Bandyopadhyay R; Bhattacharya B
    J Indian Med Assoc; 2008 Aug; 106(8):508, 510, 515. PubMed ID: 18975510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines and their role in pathogenesis of diabetic retinopathy].
    Tret'iak EB; Syroedova ON; Neuhaus O; Andreeva AV; Antsiferov MB; Mkrtumian AM; Suchkov SV
    Vestn Oftalmol; 2010; 126(6):53-7. PubMed ID: 21395004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunopathological process in retina during development of diabetic retinopathy].
    Zhaboedov GD; Skripnik RL; Sidorova MV
    Vestn Oftalmol; 2000; 116(6):36-9. PubMed ID: 11196216
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of angiogenic growth factors in the development of diabetic complications].
    Siebert J; Reiwer-Gostomska M
    Kardiol Pol; 2009 Jan; 67(1):62-4. PubMed ID: 19253193
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Images in clinical medicine. Proliferative diabetic retinopathy.
    Rishi P; Bhende PS
    N Engl J Med; 2009 Feb; 360(9):912. PubMed ID: 19246363
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular endothelial growth factor.
    Wirostko BM
    Ophthalmology; 2007 Oct; 114(10):1954-5. PubMed ID: 17908602
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Goon PK; Lip GY
    Eye (Lond); 2007 Jun; 21(6):838-9; author reply 838. PubMed ID: 17464310
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathology and pathogenesis of diabetic retinopathy.
    el-Gammal Y
    Bull Ophthalmol Soc Egypt; 1968; 61(65):11-22. PubMed ID: 5744607
    [No Abstract]   [Full Text] [Related]  

  • 19. Is vascular endothelial cell growth factor (VEGF) involved in the pathogenesis of diabetic nephropathy?
    Watanabe T
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S27. PubMed ID: 17995526
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of lipid thrombi in the pathogenesis of diabetic retinopathy.
    Chester EM; Banker BQ
    Arch Intern Med; 1967 Oct; 120(4):397-407. PubMed ID: 6058095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.